UniProt ID | TBX3_HUMAN | |
---|---|---|
UniProt AC | O15119 | |
Protein Name | T-box transcription factor TBX3 | |
Gene Name | TBX3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 743 | |
Subcellular Localization | Nucleus . | |
Protein Description | Transcriptional repressor involved in developmental processes. Probably plays a role in limb pattern formation. Acts as a negative regulator of PML function in cellular senescence.. | |
Protein Sequence | MSLSMRDPVIPGTSMAYHPFLPHRAPDFAMSAVLGHQPPFFPALTLPPNGAAALSLPGALAKPIMDQLVGAAETGIPFSSLGPQAHLRPLKTMEPEEEVEDDPKVHLEAKELWDQFHKRGTEMVITKSGRRMFPPFKVRCSGLDKKAKYILLMDIIAADDCRYKFHNSRWMVAGKADPEMPKRMYIHPDSPATGEQWMSKVVTFHKLKLTNNISDKHGFTLAFPSDHATWQGNYSFGTQTILNSMHKYQPRFHIVRANDILKLPYSTFRTYLFPETEFIAVTAYQNDKITQLKIDNNPFAKGFRDTGNGRREKRKQLTLQSMRVFDERHKKENGTSDESSSEQAAFNCFAQASSPAASTVGTSNLKDLCPSEGESDAEAESKEEHGPEACDAAKISTTTSEEPCRDKGSPAVKAHLFAAERPRDSGRLDKASPDSRHSPATISSSTRGLGAEERRSPVREGTAPAKVEEARALPGKEAFAPLTVQTDAAAAHLAQGPLPGLGFAPGLAGQQFFNGHPLFLHPSQFAMGGAFSSMAAAGMGPLLATVSGASTGVSGLDSTAMASAAAAQGLSGASAATLPFHLQQHVLASQGLAMSPFGSLFPYPYTYMAAAAAASSAAASSSVHRHPFLNLNTMRPRLRYSPYSIPVPVPDGSSLLTTALPSMAAAAGPLDGKVAALAASPASVAVDSGSELNSRSSTLSSSSMSLSPKLCAEKEAATSELQSIQRLVSGLEAKPDRSRSASP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
13 | Phosphorylation | RDPVIPGTSMAYHPF CCCCCCCCCHHCCCC | 15.24 | 24043423 | |
14 | Phosphorylation | DPVIPGTSMAYHPFL CCCCCCCCHHCCCCC | 13.82 | 24043423 | |
17 | Phosphorylation | IPGTSMAYHPFLPHR CCCCCHHCCCCCCCC | 11.03 | 24043423 | |
104 | Ubiquitination | EEVEDDPKVHLEAKE HHCCCCCCCCHHHHH | 49.64 | - | |
110 | Ubiquitination | PKVHLEAKELWDQFH CCCCHHHHHHHHHHH | 43.92 | - | |
118 | Ubiquitination | ELWDQFHKRGTEMVI HHHHHHHHHCCEEEE | 54.53 | - | |
121 | Phosphorylation | DQFHKRGTEMVITKS HHHHHHCCEEEEECC | 25.58 | 22210691 | |
127 | Ubiquitination | GTEMVITKSGRRMFP CCEEEEECCCCCCCC | 39.53 | - | |
128 | Phosphorylation | TEMVITKSGRRMFPP CEEEEECCCCCCCCC | 28.96 | 22210691 | |
163 | Phosphorylation | IAADDCRYKFHNSRW HHCCCCEEEECCCCE | 25.08 | - | |
185 | Phosphorylation | PEMPKRMYIHPDSPA CCCCCCEEECCCCCC | 10.50 | - | |
203 | Phosphorylation | QWMSKVVTFHKLKLT HHHHHEEEEEEEEEC | 24.02 | - | |
206 | Ubiquitination | SKVVTFHKLKLTNNI HHEEEEEEEEECCCC | 43.03 | - | |
208 | Ubiquitination | VVTFHKLKLTNNISD EEEEEEEEECCCCCC | 59.05 | - | |
265 | Phosphorylation | NDILKLPYSTFRTYL HHCEECCCCCCCCCC | 30.68 | - | |
293 | Ubiquitination | NDKITQLKIDNNPFA CCCCEEEEECCCCCC | 37.89 | - | |
301 | Ubiquitination | IDNNPFAKGFRDTGN ECCCCCCCCCCCCCC | 59.99 | - | |
313 | Ubiquitination | TGNGRREKRKQLTLQ CCCCHHHHHHHHHHH | 64.18 | - | |
335 | Phosphorylation | RHKKENGTSDESSSE HHHHHCCCCCCCHHH | 44.58 | 28348404 | |
336 | Phosphorylation | HKKENGTSDESSSEQ HHHHCCCCCCCHHHH | 40.56 | 28348404 | |
353 | Phosphorylation | FNCFAQASSPAASTV HHHHHHCCCCCHHHC | 25.44 | 22210691 | |
354 | Phosphorylation | NCFAQASSPAASTVG HHHHHCCCCCHHHCC | 22.90 | 26657352 | |
371 | Phosphorylation | NLKDLCPSEGESDAE CHHHHCCCCCCCHHH | 58.18 | 25159151 | |
375 | Phosphorylation | LCPSEGESDAEAESK HCCCCCCCHHHHHHH | 53.64 | 25159151 | |
381 | Phosphorylation | ESDAEAESKEEHGPE CCHHHHHHHHHHCHH | 53.03 | 22617229 | |
396 | Phosphorylation | ACDAAKISTTTSEEP HHHHCEECCCCCCCC | 20.99 | 23312004 | |
397 | Phosphorylation | CDAAKISTTTSEEPC HHHCEECCCCCCCCC | 37.25 | 25002506 | |
398 | Phosphorylation | DAAKISTTTSEEPCR HHCEECCCCCCCCCC | 22.87 | 25002506 | |
399 | Phosphorylation | AAKISTTTSEEPCRD HCEECCCCCCCCCCC | 33.94 | 25002506 | |
400 | Phosphorylation | AKISTTTSEEPCRDK CEECCCCCCCCCCCC | 37.56 | 21712546 | |
407 | Acetylation | SEEPCRDKGSPAVKA CCCCCCCCCCHHHHH | 41.77 | 26051181 | |
409 | Phosphorylation | EPCRDKGSPAVKAHL CCCCCCCCHHHHHHE | 18.54 | 30576142 | |
413 | Ubiquitination | DKGSPAVKAHLFAAE CCCCHHHHHHEEEEC | 31.99 | - | |
425 | Phosphorylation | AAERPRDSGRLDKAS EECCCCCCCCCCCCC | 27.39 | 23312004 | |
432 | Phosphorylation | SGRLDKASPDSRHSP CCCCCCCCCCCCCCC | 34.67 | 25159151 | |
435 | Phosphorylation | LDKASPDSRHSPATI CCCCCCCCCCCCCCC | 34.96 | 25159151 | |
438 | Phosphorylation | ASPDSRHSPATISSS CCCCCCCCCCCCCCC | 18.34 | 25159151 | |
441 | Phosphorylation | DSRHSPATISSSTRG CCCCCCCCCCCCCCC | 25.44 | 25159151 | |
443 | Phosphorylation | RHSPATISSSTRGLG CCCCCCCCCCCCCCC | 17.55 | 19276368 | |
444 | Phosphorylation | HSPATISSSTRGLGA CCCCCCCCCCCCCCC | 31.70 | 20873877 | |
445 | Phosphorylation | SPATISSSTRGLGAE CCCCCCCCCCCCCCC | 18.48 | 19276368 | |
446 | Phosphorylation | PATISSSTRGLGAEE CCCCCCCCCCCCCCH | 30.61 | 19276368 | |
456 | Phosphorylation | LGAEERRSPVREGTA CCCCHHCCCCCCCCC | 33.69 | 25159151 | |
462 | Phosphorylation | RSPVREGTAPAKVEE CCCCCCCCCCHHHHH | 25.39 | 23312004 | |
466 | Acetylation | REGTAPAKVEEARAL CCCCCCHHHHHHHCC | 49.47 | 26051181 | |
466 | Ubiquitination | REGTAPAKVEEARAL CCCCCCHHHHHHHCC | 49.47 | - | |
641 | Phosphorylation | MRPRLRYSPYSIPVP CCCCCCCCCCCCCEE | 15.78 | 28348404 | |
680 | Phosphorylation | KVAALAASPASVAVD HHHHHHCCCCEEEEC | 18.52 | 28355574 | |
683 | Phosphorylation | ALAASPASVAVDSGS HHHCCCCEEEECCCC | 17.62 | 29978859 | |
688 | Phosphorylation | PASVAVDSGSELNSR CCEEEECCCCHHHCC | 37.31 | 27732954 | |
690 | Phosphorylation | SVAVDSGSELNSRSS EEEECCCCHHHCCCC | 42.75 | 27732954 | |
694 | Phosphorylation | DSGSELNSRSSTLSS CCCCHHHCCCCCCCC | 46.28 | 27732954 | |
696 | Phosphorylation | GSELNSRSSTLSSSS CCHHHCCCCCCCCCC | 27.74 | 30206219 | |
697 | Phosphorylation | SELNSRSSTLSSSSM CHHHCCCCCCCCCCC | 32.05 | 23927012 | |
698 | Phosphorylation | ELNSRSSTLSSSSMS HHHCCCCCCCCCCCC | 31.72 | 30206219 | |
700 | Phosphorylation | NSRSSTLSSSSMSLS HCCCCCCCCCCCCCC | 28.41 | 30206219 | |
701 | Phosphorylation | SRSSTLSSSSMSLSP CCCCCCCCCCCCCCH | 29.55 | 30206219 | |
702 | Phosphorylation | RSSTLSSSSMSLSPK CCCCCCCCCCCCCHH | 27.04 | 23927012 | |
703 | Phosphorylation | SSTLSSSSMSLSPKL CCCCCCCCCCCCHHH | 17.84 | 23927012 | |
705 | Phosphorylation | TLSSSSMSLSPKLCA CCCCCCCCCCHHHHH | 27.87 | 25159151 | |
707 | Phosphorylation | SSSSMSLSPKLCAEK CCCCCCCCHHHHHCH | 16.81 | 19664994 | |
714 | Ubiquitination | SPKLCAEKEAATSEL CHHHHHCHHHHHHHH | 33.84 | - | |
714 | Acetylation | SPKLCAEKEAATSEL CHHHHHCHHHHHHHH | 33.84 | 26051181 | |
718 | Phosphorylation | CAEKEAATSELQSIQ HHCHHHHHHHHHHHH | 29.76 | - | |
719 | Phosphorylation | AEKEAATSELQSIQR HCHHHHHHHHHHHHH | 31.42 | - | |
729 | Phosphorylation | QSIQRLVSGLEAKPD HHHHHHHHCHHCCCC | 42.10 | 28555341 | |
734 | Ubiquitination | LVSGLEAKPDRSRSA HHHCHHCCCCCCCCC | 37.77 | - | |
734 | Acetylation | LVSGLEAKPDRSRSA HHHCHHCCCCCCCCC | 37.77 | 26051181 | |
738 | Phosphorylation | LEAKPDRSRSASP-- HHCCCCCCCCCCC-- | 37.66 | 20363803 | |
740 | Phosphorylation | AKPDRSRSASP---- CCCCCCCCCCC---- | 34.05 | 20363803 | |
742 | Phosphorylation | PDRSRSASP------ CCCCCCCCC------ | 32.18 | 20363803 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
719 | S | Phosphorylation | Kinase | AKT3 | Q9Y243 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TBX3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TBX3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TBX3_HUMAN | TBX3 | physical | 12005433 | |
HDAC1_HUMAN | HDAC1 | physical | 18245468 | |
HDAC2_HUMAN | HDAC2 | physical | 18245468 | |
HDAC3_HUMAN | HDAC3 | physical | 18245468 | |
HDAC5_HUMAN | HDAC5 | physical | 18245468 | |
PKHF2_HUMAN | PLEKHF2 | physical | 21516116 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
181450 | Ulnar-mammary syndrome (UMS) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-371 AND SER-375, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-371; SER-381; SER-707;SER-738; SER-740 AND SER-742, AND MASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-432; SER-438 ANDTHR-441, AND MASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-456, AND MASSSPECTROMETRY. |